explore -WSS

explore

author：Wikipedia 2025-10-02 01:08:55 - browse：6889

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Review: 'Barbie' will hit you like a shot in the heart

explore

entertainment

hotspot

WSS

Providers still hesitate to prescribe buprenorphine, study finds

New rules on organ donation and transplantation 'will bring chaos'

Generate Biomedicines machine learning biotech raises $273M

Diverse clinical trials: Why aren’t we there yet?

How artificial intelligence is being used to detect, treat cancer

Telehealth for opioid use disorder is lifesaving

focus

explore

Wikipedia

What does generative AI mean for health care? We asked experts

Death toll from an explosion and collapse of a Paris building in June climbs to 3

How to save PrEP access — and even expand it

White House touts steps to stem shortages of cancer treatments

Supreme Court strikes down use of affirmative action

Popular nasal decongestant doesn't actually relieve congestion

As demand for Covid shots wanes, Moderna seeks its next success

What to know about Saharan dust affecting the US and how it can affect health

In age of alternative facts, a scholarly course on calling out crap

Caitlin Bernard's story shows physicians can't shy from advocacy

focus

Hospitals consider fixing cancer drug shortages on their own

What to know about Saharan dust affecting the US and how it can affect health

PEPFAR is under serious threat — and so is global health

Food makers to regulators: Ultra

How medical schools plan to diversify without affirmative action

How artificial intelligence is being used to detect, treat cancer

explore

entertainment

hotspot

hotspot